NEW YORK, Sept. 17 (GenomeWeb News) - 454 has extended a one-year license to now include exclusive rights to synthesizing technologies owned by Biotage, the company said today.

New Haven, Conn.-based 454 has obtains the rights to sequencing by synthesis and pyrophosphate-based sequencing for whole genome and other high density and high-throughput applications.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.